P

Pharmala Biotech Holdings
MDMA

Last Price

Pharmala Biotech Holdings Earnings Call Summary

Pharmala Biotech Holdings Earnings

Estimates
Actual
Y-on-Y Change
Revenue
EPS

Transcripts

gainify

Events

About Pharmala Biotech Holdings Inc.

gainify

P

Pharmala Biotech Holdings Inc.

MDMA

Pharmala Biotech Holdings Inc., doing business as PharmAla, a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceuti...

Sector

Healthcare

Industry

Biotechnology

CEO

Kadysh, Nicholas

Employees

IPO Date

2022-01-11

Headquarters

1055 West Georgia Street, P.O. Box 11117, Vancouver, British Columbia, V6E 4N7, Canada

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.